Sterling Capital Management’s Wave Life Sciences WVE Stock Holding History

Sterling Capital Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.2K	Buy	2,624 +1,290	+97%	+$8.55K	﹤0.01%	2010
2026 Q1	$9.67K	Sell	1,334 -90	-6%	-$1.17K	﹤0.01%	2382
2025 Q4	$24.2K	Buy	1,424 +298	+26%	+$3.03K	﹤0.01%	2125
2025 Q3	$8.24K	Buy	1,126 +513	+84%	+$4.15K	﹤0.01%	2592
2025 Q2	$3.98K	Buy	613 +280	+84%	+$1.85K	﹤0.01%	2631
2025 Q1	$2.69K	Sell	333 -126	-27%	-$1.38K	﹤0.01%	2470
2024 Q4	$5.68K	Buy	459 +356	+346%	+$4.75K	﹤0.01%	2409
2024 Q3	$845	Buy	+103	New	+$616	﹤0.01%	2628

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Sterling Capital Management's WVE Position: Q2 2026 in Review

Sterling Capital Management increased its Wave Life Sciences (WVE) stake by 97% in Q2 2026, buying an estimated $8.55K and bringing the position to 2,624 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2010.

Sterling Capital Management first reported a position in WVE in Q3 2024 and has held it in 8 quarters since. The position peaked at $24.2K in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

Sterling Capital Management held 2,624 shares of Wave Life Sciences worth $15.2K as of Q2 2026.
Sterling Capital Management bought 1,290 Wave Life Sciences shares in Q2 2026, an estimated $8.55K.
Wave Life Sciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2010 holding.
Sterling Capital Management first reported a position in Wave Life Sciences in Q3 2024 and has held it in 8 quarters since.
Sterling Capital Management's Wave Life Sciences position peaked at $24.2K in Q4 2025.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.